Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome.

Lunn, Michael P; Carr, Aisling C; Keddie, Stephen; Pakpoor, Julia; Pipis, Menelaos; Willison, Hugh J

Lunn, Michael P; Carr, Aisling C; Keddie, Stephen; Pakpoor, Julia; Pipis, Menelaos; Willison, Hugh J.

Lunn MP; Department of Neuromuscular Diseases, University College London, London, UK.
Carr AC; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
Keddie S; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
Pakpoor J; Department of Neuromuscular Diseases, University College London, London, UK.
Pipis M; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
Willison HJ; Oxford School of Public Health, Oxford, UK.

Brain ; 144(5): e47, 2021 06 22.

Article en En | MEDLINE | ID: mdl-33822006

Asunto(s)

COVID-19; Síndrome de Guillain-Barré; Humanos; Estudios Longitudinales; Imitación Molecular; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Guillain-Barré / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google